Research Article

The Role of the Basal Core Promoter (BCP) and Precore Codon 28 Mutations in the Treatment Response to the Pegylated Interferon

• Şükran KÖSE
• Süheyla Serin SENGER
• Gülsün ÇAVDAR
• Pelin ADAR

The Evaluation of the Side Effects of Pegilated Interferon Monotherapy and Pegilated Interferon /Lamivudin Treatment in Patients With Chronic Hepatitis B

• Kutbettin DEMİRDAĞ
• Gülden ESER KARLIDAĞ

The Effectivity of Combination of Standard Interferon-a + Ribavirin and Pegylated Interferon-a + Ribavirin Therapy in Patients with Chronic Hepatitis C

• Nail ÖZGÜNES
• Fatma SARGIN
• Saadet YAZICI
• Nüket CEYLAN
• Ayse Canan ÜÇISIK
• Pinar ERGEN
• Arzu DOGRU
• Özlem AYDIN

Evaluation of 219 Patients with Chronic Hepatitis C Receiving Pegylated Interferon + Ribavirin Treatment

• Nevil AYKIN
• Figen ÇAĞLAN ÇEVİK
• Hasan NAZ
• Pınar KORKMAZ
• Tercan US

Hepatitis C Prevalence and Responses to Pegylated Interferon + Ribavirin Treatment Among Prisoners

• Hasan Selçuk ÖZGER
• Ömer KARAŞAHİN
• Mehmet Armağan TOY
• Sibel İBA YILMAZ
• Kenan HIZEL

Case Report

Development of Acute Pancreatitis Due to Pegylated Interferon Alpha 2a in a Patient with Chronic Hepatitis B: A Case Report

• Şükran KÖSE
• Melda TÜRKEN
• Mehmet TANRISEV
• Gülgün AKKOÇLU

Chronic Hepatitis C Treatment-Related Skin Rash: A Report of Two Cases

• Tuğba ARSLAN GÜLEN
• Ayfer İMRE

Dermatological Side Effects in a Patient with Hepatitis C Infection During Treatment with Pegylated Interferon/Ribavirin+Telaprevir: A Case Report

• Tugba SARI
• Suda Tekin KORUK
• Fatih TEMOÇIN

Sensorineural Hearing Loss Due to Pegylated Interferon Alfa/Ribavirin Therapy: A Case Report

• Tuğba SARI
• Süda TEKİN KORUK
• Alaaddin ZİREK

Review

The Problem of Access to Hepatitis B Treatment in the Balkan Country of North Macedonia

• Marija Dimzova
• Mile Bosilkovski
• Boban Toshevski